NCT04710537View on ClinicalTrials.gov

Comparing AlloDerm and DermACELL in Breast Reconstruction

NACompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

October 21, 2021

Primary Completion Date

July 26, 2022

Study Completion Date

July 26, 2022

Conditions
Acellular Dermal Matrix in Breast Reconstruction
Interventions
OTHER

AlloDerm

Enrolled patients will have one of their breasts reconstructed with AlloDerm at the time of their breast reconstruction surgery.

OTHER

DermACELL

Enrolled patients will have one of their breasts reconstructed with DermACELL at the time of their breast reconstruction surgery.

Trial Locations (2)

20016

DAVinci Plastic Surgery, Washington D.C.

Sibley Memorial Hospital, Washington D.C.

All Listed Sponsors
lead

Johns Hopkins University

OTHER

NCT04710537 - Comparing AlloDerm and DermACELL in Breast Reconstruction | Biotech Hunter | Biotech Hunter